Literature DB >> 19945376

Epithelial-mesenchymal transitions in development and disease.

Jean Paul Thiery1, Hervé Acloque, Ruby Y J Huang, M Angela Nieto.   

Abstract

The epithelial to mesenchymal transition (EMT) plays crucial roles in the formation of the body plan and in the differentiation of multiple tissues and organs. EMT also contributes to tissue repair, but it can adversely cause organ fibrosis and promote carcinoma progression through a variety of mechanisms. EMT endows cells with migratory and invasive properties, induces stem cell properties, prevents apoptosis and senescence, and contributes to immunosuppression. Thus, the mesenchymal state is associated with the capacity of cells to migrate to distant organs and maintain stemness, allowing their subsequent differentiation into multiple cell types during development and the initiation of metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19945376     DOI: 10.1016/j.cell.2009.11.007

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  2000 in total

1.  Yin-Yang1 is required for epithelial-to-mesenchymal transition and regulation of Nodal signaling during mammalian gastrulation.

Authors:  Mary C Trask; Kimberly D Tremblay; Jesse Mager
Journal:  Dev Biol       Date:  2012-06-02       Impact factor: 3.582

Review 2.  Role of Forkhead Box Class O proteins in cancer progression and metastasis.

Authors:  Chang Geun Kim; Hyemin Lee; Nehal Gupta; Sharavan Ramachandran; Itishree Kaushik; Sangeeta Srivastava; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Semin Cancer Biol       Date:  2017-08-01       Impact factor: 15.707

3.  Divergent regulation of Wnt-mediated development of the dorsomedial and ventrolateral dermomyotomal lips.

Authors:  Stefanie Krück; Martin Scaal
Journal:  Histochem Cell Biol       Date:  2012-06-06       Impact factor: 4.304

4.  BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.

Authors:  Shuai Xiao; Longfei Liu; Min Fang; Xiaojun Zhou; Xiuda Peng; Jianwu Long; Xianzhou Lu
Journal:  Dig Dis Sci       Date:  2014-11-02       Impact factor: 3.199

5.  Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.

Authors:  Runlin Shi; Haibing Xiao; Tao Yang; Lei Chang; Yuanfeng Tian; Bolin Wu; Hua Xu
Journal:  Front Med       Date:  2014-11-03       Impact factor: 4.592

6.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

7.  Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma in situ through activation of TGFβ signaling.

Authors:  Pang-Kuo Lo; Yongshu Zhang; Yuan Yao; Benjamin Wolfson; Justine Yu; Shu-Yan Han; Nadire Duru; Qun Zhou
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

8.  Sensitizing ovarian cancer cells to chemotherapy by interfering with pathways that are involved in the formation of cancer stem cells.

Authors:  Kamola Saydaminova; Robert Strauss; Min Xie; Jiri Bartek; Maximilian Richter; Ruan van Rensburg; Charles Drescher; Anja Ehrhardt; Sheng Ding; André Lieber
Journal:  Cancer Biol Ther       Date:  2016-08-30       Impact factor: 4.742

9.  MiR-200c suppresses the migration of retinoblastoma cells by reversing epithelial mesenchymal transition.

Authors:  Xiao-Lei Shao; Yao Chen; Ling Gao
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

10.  MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.

Authors:  Chandra Bartholomeusz; Xuemei Xie; Mary Kathryn Pitner; Kimie Kondo; Ali Dadbin; Jangsoon Lee; Hitomi Saso; Paul D Smith; Kevin N Dalby; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2015-09-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.